GB Patent

GB9018134D0 — Heterocyclic derivatives

Assigned to AstraZeneca SAS · Expires 1990-10-03 · 36y expired

What this patent protects

The invention concerns a heterocyclic derivative of the formula I <CHEM> wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; X<1> is oxy, thio, sulphinyl, sulphonyl or imino;…

USPTO Abstract

The invention concerns a heterocyclic derivative of the formula I <CHEM> wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; X<1> is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R<1> is (1-6C)alkyl, (3-6C)alkenyl or (3-6C)alkynyl; and R<2> and R<3> together form a group of the formula -A<2>-X<2>-A<3>- which, together with the carbon atom to which A<2> and A<3> are attached, defines a ring having 4 to 7 ring atoms, wherein A<2> and A<3>, which may be the same or different, each is (1-4C)alkylene and X<2> is oxy, thio, sulphinyl, sulphonyl or imino; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

Drugs covered by this patent

Patent Metadata

Patent number
GB9018134D0
Jurisdiction
GB
Classification
Expires
1990-10-03
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.